Free On-line Access

SPCI - Sociedade Portuguesa de Cuidados Intensivos

Revista Brasileira de Terapia Intensiva

AMIB - Associação de Medicina Intensiva Brasileira

OFFICIAL JOURNAL OF THE ASSOCIAÇÃO BRASILEIRA DE MEDICINA INTENSIVA AND THE SOCIEDADE PORTUGUESA DE CUIDADOS INTENSIVOS

ISSN: 0103-507X
Online ISSN: 1982-4335

Ícone Fechar

How to Cite


 

Bueno FU, Piva JP, Garcia PCR, Lago PM, Einloft PR. Evolução e característica de lactantes com bronquiolite viral aguda submetidos à ventilação mecânica em uma unidade de terapia intensiva pediátrica brasileira. Rev Bras Ter Intensiva. 2009;21(2):174-182

 

 

2009;21(2):174-182
Artigo Original - Pediatria

http://dx.doi.org/10.1590/S0103-507X2009000200010

Outcome and characteristics of infants with acute viral bronchiolitis submitted to mechanical ventilation in a Brazilian pediatric intensive care

Evolução e característica de lactantes com bronquiolite viral aguda submetidos à ventilação mecânica em uma unidade de terapia intensiva pediátrica brasileira

Fernanda Umpierre BuenoI, Jefferson Pedro PivaII, Pedro Celiny Ramos GarciaIII, Patrícia Miranda LagoIV, Paulo Roberto EinloftV

IPhysician at Pediatric Intensive Care Unit at Hospital São Lucas - Pontificia Universidade Católica do Rio Grande do Sul PUCRS - Porto Alegre (RS), Brazil
IIAssociate Professor of Pediatrics at Pontificia Universidade Católica do Rio Grande do Sul PUCRS - Porto Alegre, RS and Universidade Federal do Rio Grande do Sul UFRGS - Porto Alegre (RS), Brazil
IIIAssociate Professor of Pediatrics at Pontificia Universidade Católica do Rio Grande do Sul PUCRS - Porto Alegre (RS), Brazil
IVPhysician of Pediatric Intensive Care Researching Group and Pediatric Post Graduation Program at Pontificia Universidade Católica do Rio Grande do Sul PUCRS - Porto Alegre (RS), Brazil

This research was partially supported by the Brazilian Research Council (CNPq).

The above authors declare that they do not have any potential conflict of interest in this study.

Submetido em 17 de Abril de 2009
Aceito em 29 de Maio de 2009

Corresponding author:

Jefferson Pedro Piva
UTI pediátrica Hospital São Lucas da PUCRS
Av. Ipiranga 6.690 - 5º andar
CEP: 90.610-000 - Porto Alegre (RS), Brazil
Phone/Fax: 55 (51) 3315-2400
E-mail: [email protected]

 

Abstract

OBJECTIVE: To describe the characteristics and the outcome of infants with acute viral bronchiolitis submitted to mechanical ventilation.
METHODS: We performed a retrospective study enrolling all infants (less than 12 months old) admitted with the diagnosis of acute viral bronchiolitis and submitted to mechanical ventilation in an university affiliated Brazilian pediatric intensive care unit between March, 2004 and September, 2006 (3 consecutives winters). The mechanical ventilation parameters' employed on 1st, 2nd, 3rd, 7th day and before extubation were evaluated as well as the evolution (mortality rate, presence of acute respiratory distress syndrome and the prevalence of complications). The groups were compared using the Student t test, the Mann-Whitney U test and the Chi-square test.
RESULTS: Fifty-nine infants were included (3.8 ± 2.7 months old, 59% male), with 9.0 ± 9.4 days on mechanical ventilation. Prior mechanical ventilation, non invasive ventilation was instituted in 71% of children. Anemia was observed in 78% of the sample. In 51 infants (86.5%) the lower airway obstructive pattern was maintained up to tracheal extubation with a nil mortality and low prevalence of pneumothorax (7.8%). Acute respiratory distress syndrome occurred in 8 infants (13.5%), with higher mortality and a higher prevalence of pneumothorax (62.5%).
CONCLUSIONS: The declining mortality in acute viral bronchiolitis is observed even in non developed regions, involving children with high rates of anemia and premature labor. The low mortality is associated with the maintenance of the lower airway obstructive pattern during the period on mechanical ventilation. The development of acute respiratory distress syndrome is associated with increased mortality and higher prevalence of complications, representing the actual challenge in the management of children with severe acute viral bronchiolitis.

Keywords: Bronchiolitis, viral/therapy; Respiration, artificial; Intubation, intratracheal; Acute respiratory distress syndrome

 

 

INTRODUCTION

Acute viral bronchiolitis (AVB) is the most frequent lower airway infection in the first two years of life. The disease is much more severe in young infants, premature newborns and in children with underlying diseases such as bronchopulmonary dysplasia, immunodeficiencies and congenital heart defects.(1-8) AVB has a seasonal pattern, predominating in the autumn and winter seasons.(5-7,9) The respiratory syncytial virus (RSV) is the main etiological agent being followed by adenovirus, parainfluenza, influenza, rhinovirus, metapneumovirus, coronavirus and mycoplasma.(1,9-13)

Despite of the medical advances, the rate of hospitalization in children with AVB has increased during lasts years.(5,6,13) Between 1 and 3% of the infants with AVB are hospitalized and up to 15% of them are admitted to the pediatric intensive care unit (PICU).(2,5,13,14) In the last decade the non invasive ventilation (NIV) as well as the continuous positive airway pressure (CPAP) applied either by nasal prongs or through facial mask have been increasingly used in young children with AVB.(15-18) Some studies demonstrated that mechanical ventilation (MV) could be substantially reduced when CPAP or NIV are offered to infants with severe AVB.(18) However this possible benefit is still matter of debate in consequence of the paucity of well designed randomized studies as well as the non uniform indications for mechanical ventilation in the different parts of the world.(2,7,9, 13 -21) Nevertheless MV is still provided to 1% to 15% of the hospitalized children with AVB being higher among infants with cardiac or chronic respiratory diseases.(2,16-28) The mortality rate in children with AVB submitted to MV ranges between 1 and 7%, as well as is associated with high rate of complications (pneumothorax, secondary lung infection, sepsis, progressive respiratory failure and multiple organ failure).(9,14,18-20,24,25,28)

Typically, AVB presents as a lower airway obstructive lung disease (hyperinflation, wheezing and respiratory distress). However few patients might develop a restrictive lung disease pattern compatible with acute respiratory distress syndrome (ARDS), that has higher mortality and a higher prevalence of complications.(13,26,29-31)

Most of studies describing the outcome of children with AVB on mechanical ventilation are based on European and/or North American reports.(9,18,20,22,23,32,33) To our knowledge there are no published studies conducted in Latin America describing the outcome and the pattern of MV provided to infants with AVB. We hypothesize that the outcome of Latin-American children with AVB submitted to MV would be affected by some typical aspects of this region (e.g.: high prevalence of anemia and low numbers of pediatric intensive care beds available, which delays and restricts children admission to the PICU).(34) The purpose this study was to evaluate the evolution of infants with AVB and submitted to MV in one referral Brazilian PICU, describing the characteristics (parameters) of MV and relating it to the outcome (survival, ARDS, complications) and to the age.

 

METHODS

A retrospective observational study was conducted including all infants (less than 12 months old), admitted to the PICU at Hospital São Lucas from Pontificia Universidade Católica do Rio Grande do Sul (PUCRS) - Brazil, with the diagnosis of AVB and submitted to MV between March 1, 2004 and September 30, 2006 (covering three consecutive winters). The study was approved by the Ethics and Research Committee at PUCRS.

This university affiliated PICU is located in Porto Alegre (southern region of Brazil) and has 12 beds, with an average annual admission of 450 patients (0 to 15 years old), 55% of them are submitted to MV and the general mortality rate ranges between 7 and 9%. It is a referral PICU for medical and surgical diseases including advanced programs of kidney transplant, neurosurgery and cardiac surgery.

Children with severe AVB not responding to oxygen delivered by mask or nasal prongs are submitted to nasal CPAP (pressure up to 10 cmH2O) or bi-level non-invasive ventilation (5 and 10 to 15 cmH2O). MV support is indicated at the discretion of the PICU medical staff and is based on the lack of response to CPAP or NIV as well as on clinical aspects (apnea, severe respiratory distress, refractory hypoxemia). The patients are ventilated preferably in the controlled pressure mode, with synchronized intermittent mandatory ventilation plus pressure support using the Siemens Servo I or Siemens Servo 300 ventilators.

Infants (less than one year old) on MV with a clinical diagnosis of AVB defined by the first episode of wheezing associated with the presence of signs and symptoms of acute viral infection and signs of respiratory distress were included. All children included in this study, had samples of nasopharyngeal secretions collected to perform direct immunofluorescence test to identify the most common virus (Respiratory Syncytial Virus, Adenovirus, Parainfluenza and Influenza).

We excluded children with previous tracheostomy, chronic pulmonary disease (eg.: bronchopulmonar dysplasia, confirmed or possible diagnosis of cystic fibrosis) oxygen-dependent patients, severely compromised central nervous system and a prior history of MV beyond the neonatal period.

A single researcher (FB) reviewed the medical charts and collected all data selected for this study: age, weight, length of stay in the PICU, main indication for MV, length of MV, outcome in the 48 hours after extubation, PICU outcome (survival or death), the etiological virus agent, associated diagnosis with bronchiolitis, medication used before start MV (antibiotics, corticosteroids, nebulizations with ß2-agonist), transfusions performed throughout the PICU stay, moment of the first blood transfusion and hemoglobin level at that time. In this study anemia was defined as hemoglobin serum levels below than 10 g/dl.

In this PICU every patient submitted to MV has a specific flow sheet where the MV settings are reported. Every change in the MV parameters is reported in this flow sheet with the respective time. Some of these MV parameter's (peak inspiratory pressure (PIP), positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO2) and respiratory rate (RR)) were evaluated sequentially: at the end of the first 6 hours on MV, at 2nd, 3rd and 7th days and 6 hours before tracheal extubation. The higher values reported during the specific day were included in the study.

Two researchers (FB and JP) evaluated independently the medical charts and the chest x-ray looking for the clinical evolution of the lung disease. It was necessary 100% of agreement to classify the children in two groups: a) Obstructive group - children that maintained the lower airway obstructive pattern up to tracheal extubation. The inclusion criteria were: signs of lung hyperinflation in all chest x-ray up to the extubation and MV with a FiO2 equal or inferior to 60%; b) ARDS group - children that presented the arterial oxygen partial pressure(PaO2)/FiO2 ratio below 200 mmHg, with a diffuse pulmonary infiltrate without hyperinflation in the chest x-ray and absence of cardiogenic pulmonary edema (or fluid lung overload).(9,13,26,29,33)

Statistical analysis: The continuous variables were expressed by means with the respective standard deviation and were compared using the Student t test (when demonstrate normal distribution) or the U Mann-Whitney test for asymmetrical distribution. Categorical variables were expressed as percentage and were compared with the Chi-square test or exact Fisher test.

 

RESULTS

During the 30 months of the study (covering three consecutive winters), 1204 children were admitted to the PICU, being 59 infants (less than one year old) with AVB submitted to MV (4.9% of all PICU admissions and 9.2% of patients on MV). The mean time on MV was 9.0 ± 9.4 days, with a median of 12 days in the PICU. The mean age was 3.8 ± 2.7 months old, the mean weight was 5.5 ± 2.2 kg and 59% of them were male. Prior MV, NIV or nasal CPAP were instituted in 71% of children (Table 1). The causes for indicating MV were: fatigue (73%), hypoxemia (15 %) and apnea (12%). There wasn't any indication of MV due to cardiorespiratory arrest. RSV was the main etiological agent (69.5%) followed by parainfluenza (20%) and adenovirus (5%).

Transfusion with packed red cells was indicated in 46 children (78%) during the MV support, being the hemoglobin levels before transfusion of 7.5 ± 1.0 g/dL. The initial transfusion of packed red cells occurred at 4.0 ± 4.3 days of MV with an average of 16.5 ±10.8 ml/kg per patient.

The mortality rate in this series was 6.8% (4/59). In the survival group (55 patients), the extubation failure was observed in 4 patients (7.3%), being fatigue the main reason for reinstitution the MV in the first 48 hours after tracheal tube withdrawn. The mean age in the extubation failure group was 3.8 ± 2.8 months (versus 3.7 ± 2.7 months in the "extubation success" group; p= 0.97).

In 51 infants (86.5%) the lower airway obstructive pattern was maintained during all the time they were submitted to MV (obstructive group), without any deaths in this group. On the other hand, there were 8 infants (13.5%) that developed acute respiratory distress syndrome between the 3rd and 7th day of MV (ARDS group), and the four deaths occurred in this group.

In the obstructive group, 42 infants (82.3%) had a positive virology result being the RSV the most frequent agent (88%). Children with positive and negative virology had no differences regarding demographic characteristics, treatment or outcomes; being analyzed as a unique group. Stratifying the 51 infants of the obstructive group according to their age (older and younger than three months old), we observed that the younger infants stayed longer time in the PICU (p= 0.039), but without differences regarding the length on MV. Fatigue was the main reason for indicating MV in both groups of age; nevertheless apnea was identified just in young infants (20%). The prevalence of RSV, prematurity, cardiac disease, prior treatment with NIV or nasal CPAP and incidence of pneumothorax or extubation failure was the same in younger and older infants (Table 2).

The peak inspiratory pressure (PIP) in the obstructive group remained close to 30 cmH2O during days 1,2,3,7 and even on the extubation day, without difference between the younger and older infants. The only difference occurred on the first 6 hours of MV, when infants older than 3 months used slight higher PIP (32.3 ± 3.9 cmH2O versus 30.2 ± 3 cmH2O; p= 0.032). In figure 1 it is shown that the groups did not present differences regarding the FiO2 levels (which remained constant between 0.3 and 0.4), the respiratory rate, which varied from 16 to 20 rpm, with a mean of 11 rpm at the 6th hour before extubation, independent of age group analyzed.

The eight infants with AVB who developed ARDS (Table 3) were older than the 51 infants in the obstructive group (5.4 versus 3.6 months; p=0.01). Although the initial hemoglobin level was not different between the two groups on the day of the first transfusion, the ARDS group received, on average, a greater volume of packed red cells during MV (28.8 ± 9.9 ml/kg versus 13.9 ± 9.2 ml/kg; p<0.01). Compared to the obstructive group, the MV parameter's in the ARDS group were different just on the 7th day of MV, when presented higher PIP, PEEP, respiratory rate and FiO2, as well as, higher prevalence of pneumothorax (62.5% versus 7.8%, p=0.001).

 

DISCUSSION

In the Southern of Brazil AVB occurs as epidemic outbreaks being one of the main reasons for PICU admission and MV support in infants (respectively 4.9% and 9.4% in this study). The magnitude of these numbers could be even higher, considering that in this study we didn't include children with AVB older than 12 months.

Aside the known public health problems in this region,(1,35) this group of infants with AVB on MV have unquestionable associated risk factors such as: high rate of anemia (78%) requiring blood transfusion, one third were preterm newborns and two thirds didn't respond to the prior treatment with CPAP or NIV.(3,4,7,13,18,21,22) Even considering such risks, it is appealing that the observed mortality during MV (6.7%) was similar what has been reported in developed countries.(13,20,22-25,27) More intriguing is that the mortality in infants with AVB on MV seems be strongly associated with the pulmonary pattern response. Our results demonstrate that a benign evolution with a nil mortality and low rate of complications is expected when the lower airway obstructive pattern is maintained during all course of MV. On the other hand, higher mortality and elevated rate of complications are concentrated on those cases that develop ARDS.

In the last few years several studies have demonstrated that CPAP/NIV could avoid MV in infants with severe AVB.(15-18,36-38) Unfortunately, the response to this treatment is unpredictable and a substantial number of infants with AVB still need be submitted to invasive MV. The ventilatory strategy in this group is based on the respiratory physiologic changes.(2,13,32,39) AVB affects preferentially lower airways with variable intensity. The inflammatory process cause non homogeneous obstruction, leading air trapping and lung hyperinflation. The high airway resistance prolongs the time constant, enlarging the length of time to empty and inflate the alveoli. The PIP should be sufficient to overcome the high airway resistance and be accomplished with a low respiratory rate to respect the prolonged inspiratory and expiratory times.(2,13,20,32,39,40)

Similarly to our results, several studies have reported PIP between 25 and 35 cmH2O and respiratory rate lower than 30 rpm for ventilating infants with AVB.(20,36,39,40) In AVB, PIP could opening the obstructed lower airways (recruiting collapsed bronchioles), decreasing the FiO2 needs.(2,36,39,40) On the other hand, as we demonstrated, levels of PIP close to 30 cmH2O weren't associated with higher incidence of pneumothorax, even when ventilating young infants with AVB. As shown in other pulmonary obstructive diseases, the use of high PEEP doesn't avoid the lower airway obstruction neither the progressive alveolar hyperinflation.(41) Maintaining PIP close to these values, even in the weaning phase, possibly overcome both the thoracic wall resistance and airway resistance, delivering an adequate tidal volume.(2,13,20,36,39,40) We presume that the low rate of extubation failure in our study might be explained on the beneficial of this weaning strategy.

A small group of patients with AVB changes the natural course and progress to ARDS manifested by reduced pulmonary compliancy due to alveolar and interstitial involvement.(26) Similarly what was reported previously, we observed that 13.5% of children with AVB developed ARDS between the 3rd and 7th day of MV, with high rate of complications and elevated mortality. In such circumstances, the ventilatory strategy is based on high PEEP (proportional to the FiO2 requirements), low PIP and low tidal volumes (to avoid alveolar hyperdistension). Nevertheless the mortality rate is still high oscillating between 30 and 50%.(26,30,31) Aside the protective ventilatory strategy, some other adjunct therapy should be better evaluated in this condition as: exogenous surfactant administration, support ventilation with high frequency oscillation, corticosteroids and other therapies.(13,14,29,38,42,43)

The ARDS pattern in children with AVB submitted to MV could be primarily associated with: a) The specific virus agent Influenza virus, rhinovirus and adenovirus have been associated with worst evolution and poor outcome;(1,7,10,11,13,19,21,23,24) b) Factors involved with the individual immune response have been associated with poor outcome (genetic predisposition, pro/anti-inflammatory imbalance response); (13,19,21,23,26) c) Ventilator-induced lung injury can't be ruled as an isolated or associated factor with ARDS pattern in the course of MV in this group of children with AVB.(9,20,31,33) While we do not identify the exact mechanism causing ARDS in children with AVB we will not be able to offering the effective strategies to decrease the crude mortality in this challenge situation.

We are aware that we could have some bias in this retrospective study based on data extraction from single referral center and without the strict standardization to manipulate the respirator parameters. Another aspect that is inherent to the vast majority of studies evaluating MV relays on the subjective basis for indicating and withdrawing the MV.(2,9,13-18,26,33,36) In the present study, this aspect could be responsible for the excellent outcome observed in the group that maintained the lower obstructive pattern. However, when comparing with similar studies the other variables were quite similar (indications for MV, MV parameters, length of MV and lack of response to prior CPAP and NIV).(2,9,13-18,26,33,36) Consequently, even considering these methodological aspects, we strongly believe that our results reflects the local reality as well as are quite comparable what has been reported in other regions of the planet.

 

CONCLUSION

We demonstrate that the declining mortality rate in AVB (between 1 and 7%)(13,20,22-25,27) is observed even in non developed regions, involving children with high rates of anemia and premature labor. Another important finding in this study is that the low mortality in children with AVB is associated with the maintenance of the lower airway obstructive pattern during the period on MV. On the contrary, those children that developed ARDS had an increased mortality rate and higher prevalence of complications, representing the actual challenge in the management of children admitted to the PICU with AVB.

 

REFERENCES

1. Calegari T, Queiroz DA, Yokosawa J, Silveira HL, Costa LF, Oliveira TF, et al. Clinical-epidemiological evaluation of respiratory syncytial virus infection in children attended in a public hospital in midwestern Brazil. Braz J Infect Dis. 2005;9(3):156-61.

2. Rodríguez Núñez A, Martinón Torres F, Martinón Sanchez JM; Sociedad Española de Cuidados Intensivos Pediátricos. [Ventilation in special situations. Mechanical ventilation in bronchiolitis]. An Pediatr (Barc). 2003;59(4):363-6. Spanish.

3. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22(2 Suppl):S40-4; discussion S44-5.

4. Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J. 2003;22(2 Suppl):S33-7; discussion S37-9.

5. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-6.

6. Fjaerli HO, Farstad T, Bratlid D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr. 2004;4(1):25.

7. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003;143(5 Suppl):S112-7.

8. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165(9):1285-9.

9. Tasker RC, Gordon I, Kiff K. Time course of severe respiratory syncytial virus infection in mechanically ventilated infants. Acta Paediatr. 2000;89(8):938-41.

10. Straliotto SM, Siqueira MM, Muller RL, Fischer GB, Cunha ML, Nestor SM. Viral etiology of acute respiratory infections among children in Porto Alegre, RS, Brazil. Rev Soc Bras Med Trop. 2002;35(4):283-91.

11. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344(25):1917-28. Comment in: N Engl J Med. 2001;345(15):1132-3. N Engl J Med. 2001;345(15):1132; author reply 1133.

12. Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J. 2003;22(2 Suppl):S6-10; discussion S10-2.

13. Frankel LR, Derish MT. Respiratory syncytial virus-induced respiratory failure in the pediatric patient. New Horiz. 1999;7:335-46.

14. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med. 2004;5(5):482-9. Comment in: Pediatr Crit Care Med. 2004;5(5):498-500.

15. Campion A, Huvenne H, Leteurtre S, Noizet O, Binoche A, Diependaele JF, et al. [Non-invasive ventilation in infant with severe infection presumably due to respiratory syncytial virus: feasibility and failure criteria]. Arch Pediatr. 2006;13(11):1404-9. French.

16. Larrar S, Essouri S, Durand P, Chevret L, Haas V, Chabernaud JL, et al. [Effects of nasal continuous positive airway pressure ventilation in infants with severe acute bronchiolitis]. Arch Pediatr. 2006;13(11):1397-403. French.

17. Thia LP, McKenzie SA, Blyth TP, Minasian CC, Kozlowska WJ, Carr SB. Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in bronchiolitis. Arch Dis Child. 2008;93(1):45-7. Comment in: Arch Dis Child. 2008;93(7):637-8.

18. Javouhey E, Barats A, Richard N, Stamm D, Floret D. Non-invasive ventilation as primary ventilatory support for infants with severe bronchiolitis. Intensive Care Med. 2008;34(9):1608-14. Comment in: Intensive Care Med. 2008;34(9):1560-1.

19. Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr. 2003;143(5 Suppl):S142-9.

20. Chevret L, Mbieleu B, Essouri S, Durand P, Chevret S, Devictor D. [Bronchiolitis treated with mechanical ventilation: prognosis factors and outcome in a series of 135 children]. Arch Pediatr. 2005;12(4):385-90. French.

21. Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med. 2001;2(4):318-23.

22. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126(2):212-9.

23. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183(1):16-22.

24. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-86. Comment in: JAMA. 2003;289(2):227-9. JAMA. 2003;289(19):2499-500; author reply 2500-2. JAMA. 2003;289(19):2499; author reply 2500-2. JAMA. 2003;289(19):2500; author reply 2500-2.

25. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J. 2003;22(6):483-90.

26. Hammer J, Numa A, Newth CJ. Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol. 1997;23(3):176-83.

27. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127-32.

28. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61(7):611-5. Comment in: Thorax. 2006;61(12):1098. Thorax. 2007;62(3):278.

29. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med. 2006;21(3):119-43. Review.

30. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342(18):1301-8. Comment in: ACP J Club. 2001;134(1):16. N Engl J Med. 2000;342(18):1360-1. N Engl J Med. 2000;343(11):812-3; author reply 813-4. N Engl J Med. 2000;343(11):812; author reply 813-4. N Engl J Med. 2000;343(11):813; author reply 813-4.

31. Moloney ED, Griffiths MJ. Protective ventilation of patients with acute respiratory distress syndrome. Br J Anaesth. 2004;92(2):261-70. Review.

32. Kneyber MC, Blussé van Oud-Alblas H, van Vliet M, Uiterwaal CS, Kimpen JL, van Vught AJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med. 2005;31(5):680-5.

33. Lebel MH, Gauthier M, Lacroix J, Rousseau E, Buithieu M. Respiratory failure and mechanical ventilation in severe bronchiolitis. Arch Dis Child. 1989;64(10):1431-7. Comment in: Arch Dis Child. 1990;65(3):332.

34. Piva JP, Schnitzler E, Garcia PC, Branco RG. The burden of paediatric intensive care: a South American perspective. Paediatr Respir Rev. 2005;6(3):160-5.

35. Victora CG, Vaughan JP, Barros FC, Silva AC, Tomasi E. Explaining trends in inequities: evidence from Brazilian child health studies. Lancet. 2000;356(9235): 1093-8.

36. Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med. 2005;6(6): 660-4.

37. Essouri S, Chevert L, Durand P, Haas V, Fauroux B, Devictor D. Noninvasive positive pressure ventilation: five years experience in a pediatric intensive care unit. Pediatr Crit Care Med. 2006;7(4): 329-34.

38. Tasker RC. CPAP and HFOV: different guises of the same underlying intensive care strategy for supporting RSV bronchiolitis. Intensive Care Med. 2008;34(9):1560-1. Comment on: Intensive Care Med. 2008;34(9):1608-14. Intensive Care Med. 2008;34(9):1698-702.

39. Leclerc F, Scalfaro P, Noizet O, Thumerelle C, Dorkenoo A, Fourier C. Mechanical ventilatory support in infants with respiratory syncytial virus infection. Pediatr Crit Care Med. 2001;2(3):197-204.

40. Levin DL, Garg A, Hall LJ, Slogic S, Javis JD, Leiter JC. A prospective randomized controlled blinded study of three bronchodilators in infants with respiratory sincytial virus bronchiolitis on mechanical ventilation. Pediatr Crit Care Med. 2008;9(6):598-604. Comment in: Pediatr Crit Care Med. 2008;9(6):659-61.

41. Guerin C, LeMasson S, de Varax R, Milic-Emili J, Fournier G. Small airway closure and positive end-expiratory pressure in mechanically ventilated patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155(6):1949-56.

42. Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L, Marraro G. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med. 2002;3(3):261-8.

43. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, Jacobs BR, Jefferson LS, Conaway MR, Egan EA; Pediatric Acute Lung Injury and Sepsis Investigators. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293(4):470-6. Erratum in: JAMA. 2005;294(8):900.

 

 

Received from: Pediatric Department, School of Medicine at Pontificia Universidade Católica do Rio Grande do Sul - PUCRS - Porto Alegre (RS), Brazil and Pediatric Intensive Care Unit at Hospital São Lucas, Pontificia Universidade Católica do Rio Grande do Sul - PUCRS - Porto Alegre (RS), Brazil.

The present study was approved by the Ethics Research Committee at PUCRS - University (CEP-06/03068).

 

 

Submission On-line

Indexed in

Scopus

SciELO

LILACS

Associação de Medicina Intensiva Brasileira - AMIB

Rua Arminda nº 93 - 7º andar - Vila Olímpia - São Paulo, SP, Brasil - Tel./Fax: (55 11) 5089-2642 | e-mail: [email protected]

Cookie Policy

GN1 - Systems and Publications